|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3590 USD | -0.19% |
|
-0.25% | -73.21% |
| 06-08 | Soligenix Applies for Vaccine Development Funding for Bundibugyo Ebola Vaccine | CI |
| 05-29 | Soligenix - increases maximum offering under sales agreement by $2.96 million | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bearish |
| Resistance | 0.41 | 1.42 | 1.12 |
| Spread/Res. | -12.44% | -74.72% | -67.95% |
| Spread/Supp. | +1.76% | +28.17% | +22.53% |
| Support | 0.3528 | 0.2801 | 0.293 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SNGX Stock
- Charts Soligenix, Inc.
Select your edition
All financial news and data tailored to specific country editions
